Summary
A possible pathogenic mutation in the Β3-adrenergic-receptor gene (Trp64Arg) has been reported to be associated with an earlier age of onset of non-insulin-dependent diabetes mellitus (NIDDM) and clinical features of the insulin resistance syndrome in Pima Indian, Finnish and French subjects. Since marked heterogeneity has been reported in the association of mutations of candidate genes with NIDDM between Japanese and other ethnic groups, we investigated the association of Trp64Arg with NIDDM in Japanese subjects. The allele frequency of the mutation (Arg) was slightly, but not significantly, higher in NIDDM than in control subjects (70 out of 342 alleles [20.5%] vs 40 out of 248 [16.1%], respectively, p>0.2). When our data were combined with those of Pima Indian and Finnish subjects, however, the Arg/Arg genotype was significantly associated with NIDDM as compared with the other two genotypes (p<0.005, relative risk [RR] 2.13, 95% confidence interval [CI] 1.28–3.55). The Arg allele was also associated with NIDDM (p<0.05, RR 1.27, 95% CI 1.06–1.52). Japanese subjects homozygous for the mutation had a significantly higher body mass index (mean ± SD∶25.5±3.9 kg/ m2) than heterozygotes (22.6±4.1, p<0.05) and normal homozygotes (22.8±3.8, p<0.05). NIDDM patients homozygous for the mutation tended to have an earlier age of onset of NIDDM than those with other genotypes. These data suggest that the Trp64Arg mutation not only contributes to weight gain and age-at-onset of NIDDM but is also associated with susceptibility to NIDDM.
Abbreviations
- NIDDM:
-
Non-insulin-dependent diabetes mellitus
- Β3-AR:
-
Β3-adrenergic-receptor
- Trp64Arg:
-
a mutation in the Β3-adrenergic-receptor gene causing a Trp to Arg change at codon 64
- BMI:
-
body mass index
- ADRB3:
-
Β3-adrenergic receptor gene
- PCR:
-
polymerase chain reaction
- RFLP:
-
restriction fragment length polymorphism
- RR:
-
relative risk
- CI:
-
confidence interval
References
Giacobino JP (1995) Β 3-adrenoceptor: an update. Eur J Endocrinol 132: 377–385
Walston J, Silver K, Bogardus C et al. (1995) Time of onset of non-insulin-dependent diabetes mellitus and genetic variation in the Β3-adrenergic-receptor gene. N Engl J Med 333: 343–347
Widén E, Lehto M, Kanninen T, Walston J, Shuldiner AR, Groop LC (1995) Association of a polymorphism in the Β3-adrenergic-receptor gene with features of the insulin resistance syndrome in Finns. N Engl J Med 333: 348–351
Clément K, Vaisse C, Manning BSJ et al. (1995) Genetic variation in the Β3-adrenergic-receptor and an increased capacity to gain weight in patients with morbid obesity. N Engl J Med 333: 352–354
Kadowaki T, Kadowaki H, Yazaki Y (1993) Polymorphism of the glycogen synthase gene and non-insulin-dependent diabetes mellitus. N Engl J Med 328: 1568–1569
Fujisawa T, Ikegami H, Yamato E et al. (1995) A mutation in the glucagon receptor gene (Gly40Ser): heterogeneity in the association with diabetes mellitus. Diabetologia 38: 983–985
World Health Organization (1985) Diabetes mellitus: report of a WHO Study Group Second report. Geneva, World Health Organization (Tech Rep Ser, no. 727)
Hager J, Hansen L, Vaisse C et al. (1995) A missense mutation in the glucagon receptor gene is associated with non-insulin-dependent diabetes mellitus. Nature Genet 9: 299–304
Kadowaki T, Kadowaki H, Mori Y et al. (1994) A subtype of diabetes mellitus associated with a mutation of mito-chondrial DNA. N Engl J Med 330: 962–968
Kadowaki H, Yasuda K, Iwamoto K et al. (1995) A mutation in the Β3-adrenergic receptor gene is associated with obesity and hyperinsulinemia in Japanese subjects. Biochem Biophys Res Commun 215: 555–560
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Fujisawa, T., Ikegami, H., Yamato, E. et al. Association of Trp64Arg mutation of the β3-adrenergic-receptor with NIDDM and body weight gain. Diabetologia 39, 349–352 (1996). https://doi.org/10.1007/BF00418352
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00418352